Evidence map›Paper›PMID 26940866›Full record

ArticleScience (New York, N.Y.)2016

Health and population effects of rare gene knockouts in adult humans with related parents.

Vagheesh M Narasimhan, Karen A Hunt, Dan Mason, Christopher L Baker, Konrad J Karczewski, Michael R Barnes, Anthony H Barnett, Chris Bates, Srikanth Bellary, Nicholas A Bockett and 26 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 187 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
187citing papers in PubMed, 4 pooled it
47.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

187 citing papers in PubMed, 4 syntheses or guidelines pooled it, 310 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. On the origin of PRDM9-guided recombination hotspots.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. PON-P3: Accurate Prediction of Pathogenicity of Amino Acid Substitutions.International journal of molecular sciences · 2025
    Article
  19. Article
  20. Article

127 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors at 12 institutions in 2 countries.

Vagheesh M NarasimhanWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Karen A HuntBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Dan MasonBradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford BD9 6RJ, UK.
Christopher L BakerCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, ME 04609, USA.
Konrad J KarczewskiAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA. Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Michael R BarnesWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Anthony H BarnettDiabetes and Endocrine Centre, Heart of England NHS Foundation Trust and University of Birmingham, Birmingham B9 5SS, UK.
Chris BatesTPP, Mill House, Troy Road, Leeds LS18 5TN, UK.
Srikanth BellaryAston Research Centre for Healthy Ageing, Aston University, Birmingham B4 7ET, UK.
Nicholas A BockettBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Kristina Giorda10X Genomics, 7068 Koll Center Parkway, Suite 415, Pleasanton, CA 94566, USA.
Christopher J GriffithsBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Harry HemingwayFarr Institute of Health Informatics Research, London NW1 2DA, UK. Institute of Health Informatics, University College London, London NW1 2DA, UK.
Zhilong JiaWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
M Ann KellySchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK.
Hajrah A KhawajaWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Monkol LekAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA. Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Shane McCarthyWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Rosie McEachanBradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford BD9 6RJ, UK.
Anne O'Donnell-LuriaAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA. Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Kenneth PaigenCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, ME 04609, USA.
Constantinos A ParisinosBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Eamonn SheridanBradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford BD9 6RJ, UK.
Laura SouthgateBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Louise TeeSchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK.
Mark ThomasWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Yali XueWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Michael Schnall-Levin10X Genomics, 7068 Koll Center Parkway, Suite 415, Pleasanton, CA 94566, USA.
Petko M PetkovCenter for Genome Dynamics, The Jackson Laboratory, Bar Harbor, ME 04609, USA.
Chris Tyler-SmithWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, Box 238, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK. Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Richard C TrembathBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK. Faculty of Life Sciences and Medicine, King's College London, London SE1 1UL, UK.
Daniel G MacArthurAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA. Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
John WrightBradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford BD9 6RJ, UK.
Richard DurbinWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. rd@sanger.ac.uk d.vanheel@qmul.ac.uk.
David A van HeelBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK. rd@sanger.ac.uk d.vanheel@qmul.ac.uk.
Queen Mary University of London · GBWellcome Sanger Institute · GBJackson Laboratory · USBradford Teaching Hospitals NHS Foundation Trust · GBBroad Institute · USMassachusetts General Hospital · USNational Health Service · GBUniversity of Birmingham · GBAston University · GBCambridge University Hospitals NHS Foundation Trust · GBUniversity College London · GBWilliam Harvey Research Institute · GB

Funding

Computational resources for genomic interpretation of type 2 diabetesU54DK105566 · NIDDK · BROAD INSTITUTE, INC. · PI MACARTHUR, DANIEL G, NEALE, BENJAMIN MICHAEL · 2014 to 2017
$8.6M
PRDM9 and Meiotic Regulatory NetworksP01GM099640 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2013 to 2017
$8.2M
Annotation and interpretation of loss-of-function polymorphisms in human genomesR01GM104371 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MACARTHUR, DANIEL G · 2013 to 2016
$1.3M
Arthritis Research UKBritish Heart FoundationCancer Research UKChief Scientist OfficeDepartment of HealthMedical Research Council MC_PC_13042Medical Research Council MR/K006584/1Medical Research Council MR/K006665/1Medical Research Council MR/M009017/1NIDDK NIH HHS U54 DK105566NIGMS NIH HHS GM 099640NIGMS NIH HHS P01 GM099640NIGMS NIH HHS R01 GM104371NIGMS NIH HHS R01GM104371Wellcome TrustWellcome Trust WT098051Wellcome Trust WT099769Wellcome Trust WT101597Wellcome Trust WT102627
6 · The paper itself

Abstract

Examining complete gene knockouts within a viable organism can inform on gene function. We sequenced the exomes of 3222 British adults of Pakistani heritage with high parental relatedness, discovering 1111 rare-variant homozygous genotypes with predicted loss of function (knockouts) in 781 genes. We observed 13.7% fewer homozygous knockout genotypes than we expected, implying an average load of 1.6 recessive-lethal-equivalent loss-of-function (LOF) variants per adult. When genetic data were linked to the individuals' lifelong health records, we observed no significant relationship between gene knockouts and clinical consultation or prescription rate. In this data set, we identified a healthy PRDM9-knockout mother and performed phased genome sequencing on her, her child, and control individuals. Our results show that meiotic recombination sites are localized away from PRDM9-dependent hotspots. Thus, natural LOF variants inform on essential genetic loci and demonstrate PRDM9 redundancy in humans.

Indexed as

ConsanguinityHealthAdultDNA Mutational AnalysisDrug PrescriptionsExomeFemaleFertilityGene Knockout TechniquesGenes, LethalGenetic LociGenome, HumanHistone-Lysine N-MethyltransferaseHomologous RecombinationHomozygoteHumansHistone-Lysine N-MethyltransferasePRDM9 protein, human

Identifiers

PMID26940866
PMCPMC4985238
OpenAlexW2294521862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.